AU Patent

AU2020288624B2 — Silk-based products, formulations, and methods of use

Assigned to Cocoon Biotech Inc · Expires 2025-09-25 · 1y expired

What this patent protects

Embodiments of the present disclosure include formulations of silk-based product (SBP) formulations and related methods of preparation and use in a variety of applications in the fields of human therapeutics, veterinary medicine, agriculture, and material science.

USPTO Abstract

Embodiments of the present disclosure include formulations of silk-based product (SBP) formulations and related methods of preparation and use in a variety of applications in the fields of human therapeutics, veterinary medicine, agriculture, and material science.

Drugs covered by this patent

Patent Metadata

Patent number
AU2020288624B2
Jurisdiction
AU
Classification
—
Expires
2025-09-25
Drug substance claim
No
Drug product claim
No
Assignee
Cocoon Biotech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.